Published in J Neurol Neurosurg Psychiatry on December 01, 2004
Axonal degeneration in peripheral nerves in a case of Leber hereditary optic neuropathy. J Neuroophthalmol (2011) 1.10
Leber's Hereditary Optic Neuropathy: The Mitochondrial Connection Revisited. Middle East Afr J Ophthalmol (2011) 0.97
Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside. J Ophthalmol (2010) 0.96
Oxidative stress in inherited mitochondrial diseases. Free Radic Biol Med (2015) 0.81
Role of apoptosis-inducing factor (Aif) in the T cell lineage. Indian J Med Res (2013) 0.77
Multiplex MALDI-TOF MS detection of mitochondrial variants in Brazilian patients with hereditary optic neuropathy. Mol Vis (2016) 0.75
A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy. J Neurol (2005) 0.75
Optimization of a genotyping screening based on hydrolysis probes to detect the main mutations related to Leber hereditary optic neuropathy (LHON). Mol Vis (2017) 0.75
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption. J Neurol (2007) 0.75
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol (1991) 4.89
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med (1996) 4.00
A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun (1993) 3.79
Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics (1992) 2.94
Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A (1999) 2.91
Retracted Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res (2001) 2.59
Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci U S A (1999) 2.58
Leber hereditary optic neuropathy. J Med Genet (2002) 2.33
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol (2002) 2.13
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2001) 2.04
Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i. J Biol Chem (1998) 2.01
Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron (1995) 1.95
Cytochrome c oxidase mutations in Leber hereditary optic neuropathy. Biochem Biophys Res Commun (1993) 1.92
Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem (1999) 1.92
Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet (1995) 1.73
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem (1997) 1.33
Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet (2002) 1.33
Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J Biol Chem (2002) 1.30
Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol (1984) 1.26
Pre-excitation syndrome and Leber's hereditary optic neuroretinopathy. Lancet (1985) 1.21
Retinal neuroprotection by growth factors: a mechanistic perspective. J Cell Biochem (2003) 1.21
A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy. Arch Ophthalmol (1998) 1.14
Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci (2003) 1.13
Gene expression in the mouse retina: the effect of damaging light. Mol Vis (2000) 1.12
Apoptosis: molecular aspects of cell death and disease. Lab Invest (1998) 1.11
Central nervous system involvement in Leber's optic neuropathy. J Neurol (1993) 1.07
Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res (2000) 1.06
Apoptosis: checkpoint at the mitochondrial frontier. Mutat Res (1999) 1.05
Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-Induced apoptosis. J Biol Chem (2001) 1.01
mtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem Biophys Res Commun (1997) 0.99
Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain (2000) 0.98
Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress. Life Sci (2000) 0.96
Glutamate transporters and retinal excitotoxicity. Glia (2002) 0.91
Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim Biophys Acta (1995) 0.91
Inhibition of apoptosis by zinc: a reappraisal. Biochem Biophys Res Commun (1992) 0.87
Current understanding of neuroprotection in glaucoma. Curr Opin Ophthalmol (2002) 0.86
Ionizing radiation-induced death in bovine lens epithelial cells: mechanisms and influence of irradiation dose rate. Int J Cancer (2000) 0.84
Methods for detecting apoptotic cells in tissues. Histol Histopathol (1997) 0.81
Increased apoptotic response to 2-deoxy-D-ribose in ataxia-telangiectasia. J Neurol Sci (1996) 0.79
Enhanced 2-deoxy-D-ribose-induced-apoptosis, a phenotype of lymphocytes from old donors, is not observed in the Werner syndrome. Exp Gerontol (2000) 0.77
Leber's optic atrophy: VEP and BAEP changes in 16 asymptomatic subjects. Acta Neurol Scand (1991) 0.76
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28
A case-control study of gastric cancer and diet in Italy. Int J Cancer (1989) 2.17
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
A supernova origin for dust in a high-redshift quasar. Nature (2004) 1.97
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol (1989) 1.89
MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett (2000) 1.82
Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci (2006) 1.75
Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis (1997) 1.74
Autonomic dysfunction in Parkinson's disease. Neurol Sci (2003) 1.69
Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril (1992) 1.67
HIV-associated malignant lymphomas in Kenya (Equatorial Africa) Hum Pathol (1998) 1.66
Requests for electromyography from general practitioners and specialists: critical evaluation. Ital J Neurol Sci (1998) 1.59
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology (2009) 1.59
Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial. Hum Reprod (2001) 1.57
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity. Mov Disord (2000) 1.53
Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer (1991) 1.53
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol (2008) 1.52
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer (2000) 1.50
US of nerve entrapments in osteofibrous tunnels of the upper and lower limbs. Radiographics (2000) 1.49
Bcl-2 overexpression and smoking history in head and neck cancer. J Natl Cancer Inst (1995) 1.47
US and MR imaging of peripheral nerves in leprosy. Skeletal Radiol (2000) 1.44
Stage and localization of pelvic endometriosis and pain. Fertil Steril (1990) 1.44
CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL. Eur J Neurol (2008) 1.44
Late diagnosis in severe and mild intellectual disability in adulthood. J Intellect Disabil Res (2004) 1.43
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43
DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material. Br J Ophthalmol (1998) 1.43
MR-defecography in obstructed defecation syndrome (ODS): technique, diagnostic criteria and grading. Tech Coloproctol (2013) 1.42
Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. Br J Haematol (1994) 1.40
Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan. Eur J Nucl Med (1992) 1.40
Interventional musculoskeletal ultrasonography: Precautions and contraindications. J Ultrasound (2010) 1.39
Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology (2004) 1.36
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer (1990) 1.32
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26
Pre-operative assessment of bladder endometriosis. Hum Reprod (1997) 1.24
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch (1999) 1.24
Ultrasound of the elbow: Examination techniques and US appearance of the normal and pathologic joint. J Ultrasound (2007) 1.23
Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci (2010) 1.22
Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A (1995) 1.21
Tendon and nerve sonography. Radiol Clin North Am (1999) 1.21
The spectrum of mutations for CADASIL diagnosis. Neurol Sci (2005) 1.21
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain (2001) 1.21
Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology (2001) 1.20
The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry (2005) 1.19
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology (2008) 1.19
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens (1998) 1.19
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma. J Clin Oncol (2000) 1.18
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol (2006) 1.16
Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem (1994) 1.16
Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer (2002) 1.16
FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias. Leukemia (1994) 1.16
Reproducibility of histologic classification of gastric cancer. Br J Cancer (1991) 1.13
Laparoscopic creation of a neovagina in patients with Rokitansky syndrome: analysis of 52 cases. Fertil Steril (2000) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol Reprod (2001) 1.12
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group. Leukemia (2010) 1.12
Cortical lesions in radiologically isolated syndrome. Neurology (2011) 1.12
Origin of microsatellite instability in gastric cancer. Am J Pathol (1999) 1.10
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma. Blood (2000) 1.10
Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet (1997) 1.09
Ultrasound of the elbow. Skeletal Radiol (2001) 1.08
The effect of nitric oxide generators on ischemia reperfusion injury and histamine release in isolated perfused guinea-pig heart. Agents Actions (1991) 1.07
Diagnostic imaging of tumors of the hand and wrist. Eur Radiol (2001) 1.07
Gastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren's classification. Cancer (1988) 1.07
Sweet's syndrome: association with accelerated phase of chronic myeloid leukemia. Acta Haematol (1988) 1.07
Follicular Hurthle cell tumors of the thyroid gland. Cancer (1991) 1.07
Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension (1994) 1.07
Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology (2004) 1.06
Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int J Cancer (1991) 1.06
A case-control study of gastric cancer and diet in Italy. III. Risk patterns by histologic type. Int J Cancer (1991) 1.06
Evidence of Toscana virus variants circulating in Tuscany, Italy, during the summers of 1995 to 1997. J Clin Microbiol (1998) 1.06
Ultrasonography of peripheral nerves. Semin Ultrasound CT MR (2000) 1.04
Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis (2006) 1.04
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol (1998) 1.04
Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts. Neurology (2003) 1.04
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes. Prostate (2000) 1.04
The requirements of a specialist Breast Centre. Eur J Cancer (2013) 1.04
Epstein-Barr virus and gastric cancer: data and unanswered questions. Int J Cancer (1993) 1.03
Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects. Alcohol Alcohol (2000) 1.03
Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes (1994) 1.03
The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain (1998) 1.03
Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology (2010) 1.03
Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer (2007) 1.03
Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol (1995) 1.02
Accuracy of clinical diagnostic criteria for Friedreich's ataxia. Mov Disord (2000) 1.02
Double uterus with obstructed hemivagina and ipsilateral renal agenesis: pelvic anatomic variants in 87 cases. Hum Reprod (2013) 1.02